首页|2021年河南省某监测点178例乙型肝炎病毒表面抗原阳性孕妇母婴阻断效果及影响因素

2021年河南省某监测点178例乙型肝炎病毒表面抗原阳性孕妇母婴阻断效果及影响因素

扫码查看
目的 开展乙型肝炎病毒表面抗原(HBsAg)阳性母亲所产新生儿接种乙肝疫苗(HepB)和乙肝免疫球蛋白(HBIG)后血清学监测(PVST),评价其母婴阻断效果;为免疫失败的易感儿童再次接种乙肝疫苗,以降低新生儿乙型肝炎病毒(HBV)感染风险.方法 2021年,在周口市淮阳区国家PVST监测点,以HBsAg阳性母亲及其所产的新生儿为研究对象,全程接种乙肝疫苗和乙肝免疫球蛋白后1~2个月,采集静脉血开展HBsAg和乙肝病毒表面抗体(抗-HBs)检测,并对HBsAg阴性且抗-HBs阴性的易感儿童进行乙肝疫苗的再次免疫.结果 本研究共纳入178例HBsAg阳性母亲所产的新生儿,乙肝疫苗全程接种率、及时接种率、乙肝免疫球蛋白接种率均为100.0%;阻断成功174例,成功率97.8%.发现易感儿童36例,对其再次进行免疫,其中18例血清标本进行检测,全部产生了保护性抗体;18例未采集血清标本,其中7例完成了全程免疫,11例未完成.HBsAg单阳性组和HBsAg、HBeAg双阳性组的母婴阻断成功率分别为99.2%和93.6%,差异有统计学意义(Fisher确切概率法,P<0.05);母亲不同分娩年龄、文化程度、肝炎病程、分娩方式,HBV母婴传播阻断成功率差异无统计学意义(x2值分别为0.07、0.07、2.67、0.35,P均>0.05);儿童不同性别、胎龄、体重、胎次,HBV母婴传播阻断成功率差异无统计学意义(x2值分别为0.69、0.48、0.00、1.10,P均>0.05).结论 对HBsAg阳性母亲所产新生儿实施HepB和HBIG联合免疫且开展抗体水平监测可及时发现易感儿童,进行再次免疫可提高阻断成功率.
Mother-to-child transmission blocking and its influencing factors in 178 cases of HBsAg positive pregnant women at a monitoring site in Henan Province in 2021
Objective To conduct post-vaccination serological test(PVST)on newborns born to mothers for hepatitis B virus surface antigen(HBsAg)positive after immunized with hepatitis B vaccine(HepB)and hepatitis B immunoglobulin(HBIG),to evaluate the effectiveness of mother-to-child transmission blocking of the treatment.Non-responsive babies were re-vaccinated with the hepatitis B vaccine,aiming to reduce the risk of neonatal HBV infection.Methods Newborns born to HBsAg-positive mothers in Huaiyang District,a national PVST monitoring site in Zhoukou City,Henan Province in 2021,were selected as study objects.Blood samples were collected for antibody monitoring within 1-2 months after immunized with hepatitis B vaccine and hepatitis B immunoglobulin concurrently.Babies with HBsAg negative and anti-HBS negative were re-immunized with hepatitis B vaccine.Results A total of 178 subjects were included in the study.All newborns were immunized with HepB and HBIG timely.Successful blocking was achieved in 174 cases,resulting in a 97.8%success rate.Among 36 susceptible children identified,18 completed the re-immunization and all protective antibodies,yielding a 100.0%re-immunization success rate.No specimens were collected from18 newborns.Among them,7 completed the immunization and 11 did not.The success rate of mother-to-child blocking was significantly higher in HBsAg group(99.2%)than in the HBsAg+HBeAg group(93.6%)(P<0.05).No significant differences were observed in success blocking rates across different maternal ages,education levels,courses of hepatitis,or delivery modes(x2=0.07,0.07,2.67,0.35,P>0.05).Similarly,no significant differences were found among children of different sexes,gestational age,parities and weight(x2=0.69,0.48,0.00,1.10,P>0.05).Conclusions For newborns born to HBsAg positive mothers,the combination of HepB and HBIG immunization and antibody level monitoring can effectively identify and re-immunize susceptible children,thereby improving the success rate of blocking immunization.

Hepatitis BMother-to-child blockingInfluencing factors

李军、韦亚名、杨凯朝、张肖肖、史鲁斌、豆巧华、郭永豪、姬艳芳、杜冰会、张延炀

展开 >

河南省疾病预防控制中心,河南郑州 450016

周口市淮阳区疾病预防控制中心

乙型肝炎 母婴阻断 影响因素

2024

河南预防医学杂志
河南省预防医学会

河南预防医学杂志

影响因子:0.409
ISSN:1006-8414
年,卷(期):2024.35(8)
  • 19